[ad_1]
The new study by an Israeli team, not yet peer-reviewed or published, aimed to clearly identify the anti-inflammatory properties of cannabis by recruiting 46 patients with Crohn's disease. The randomized controlled trial administered one half of the cohort treatment with cannabis oil lasting eight weeks and another placebo. In addition to monitoring the severity of symptoms, the researchers measured inflammation in the intestine both endoscopically and via biomarkers in the blood and stool.
[ad_2]
Source link
